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The accumulation of misfolded proteins occurs during cellular stress and aging and is a common feature of many neuro-
degenerative disorders. Recent work provides insights into the mechanisms by which cells detect and respond to the
presence of misfolded proteins. This includes the discovery that misfolded proteins preferentially accumulate in one of
two cellular compartments. Other new findings reveal proteins involved in the retrotranslocation of misfolded glycopro-
teins, uncover mechanisms regulating proteolysis of misfolded proteins, and suggest new strategies for the treatment of
diseases associated with protein aggregation.
Misfolded Proteins Have a Parting of Ways
According to newwork by Kaganovich et al. (2008), different classes ofmisfolded pro-
teins partition to two separate intracellular compartments, one next to the nucleus
(juxtanuclear) and the other near vacuoles (perivacuolar). By examining the cellular
distribution of multiple misfolded proteins in both yeast and mammalian cells, the
authors propose a stunningly simple model: soluble ubiquitinated proteins go to the
juxtanuclear compartment, whereas insoluble terminally misfolded proteins accumu-
late in the perivacuolar compartment. In addition to the spatial segregation, the fate of
the proteins in these two compartments appears to be equally divergent. For exam-
ple, proteins in the juxtanuclear compartment are in close proximity to cytoplasmic
concentrations of the 26S proteasome, whereas the perivacuolar compartment is
marked by proteins implicated in autophagy. Although in most cases the juxtanuclear
compartment appears to be the compartment of first resort for protein quality control,
the authors demonstrate that disease-causing Huntingtin and prion proteins preferentially partition to the perivacuolar com-
partment. Is this preferential sorting a mechanism of cellular protection that sequesters these dangerous proteins for long-
term storage and disposal? Or does this reflect the fact that these misfolded proteins interact inefficiently with the normal
quality-control machinery and as a consequence are shunted to the perivacuolar pathways by default? Although this question
is unresolved, the answer may be highly relevant to understanding the pathogenesis of diseases associated with protein
misfolding. Intriguingly, the authors demonstrate that enhancing the ubiquitination of a prion protein enhances its partitioning
to the juxtanuclear compartment. Likewise, blocking the ubiquitination of proteins that normally go to the juxtanuclear com-
partment leads them to partition to the perivacuolar protein. If enhancing the partitioning of misfolded proteins that cause
disease to one of these compartments were to lessen their toxicity, these efforts might form the basis of a cellular assay
with which researchers can screen for new therapeutic compounds.
D. Kaganovich et al. (2008). Nature 454, 1088–1095.
Lon Takes in the Aromatic Fragrance of Unfolded Proteins
How do you clear toxic aggregates of unhealthy proteins that are irreversibly
misfoldedwhile leaving healthy proteins intact even if temporarily misfolded?
In their current work, Gur and Sauer (2008) confront this question, studying
the mechanisms by which Lon, an AAA+ protease from the bacterium
Escherichia coli, recognizes permanently damaged proteins. The authors
examined the degradation of a fragment of b-galactosidase (amino acids
3–93), previously shown to be a substrate of Lon, and reveal that a particular
20 amino acid segment of the b-galactosidase fragment facilitates Lon
recognition. Moreover, if this 20 amino acid segment is added to other
proteins, it enhances their recognition and degradation by Lon. This effect
is shown to be due specifically to a patch of aromatic residues. Aromatic
amino acids, because of their marked hydrophobicity, are the residues
mostly likely to be buried in proteins in their native conformations. Indeed,
in native full-length b-galactosidase, the aromatic residues critical for Lon
recognition of the b-galactosidase fragment are buried deep within the
three-dimensional structure. The authors suggest that there is likely a dy-
namic interplay between proteases, such as Lon, that degrade misfolded
proteins and chaperones that assist refolding. They note that the sequences that Lon recognizes in its substrates occur
less frequently than do the sequences recognized by the chaperones DnaK andDnaJ. From this, they propose that the relative
abundance of recognition sites for proteases and chaperones could provide a mechanism by which permanently damaged
proteins are eliminated, while transiently misfolded proteins are spared proteolytic degradation.
E. Gur and R. T. Sauer (2008). Genes Dev. 22, 2267–2277.
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Unruly Glycoproteins Are Discharged from the ER by SEL1L and Partners
Misfolded secreted and membrane proteins are discharged from the endoplasmic reticulum (ER) for proteolytic degradation
in the cytosol. Recent efforts by Mueller et al. (2008) identify new proteins in the ER of mammalian cells that mediate the
dislocation of misfolded glycoproteins. The authors sought to understand the function of human SEL1L, an adaptor protein
in the ER previously implicated in glycoprotein dislocation. They expressed a tagged version of SEL1L in HeLa cells and iden-
tified copurifying proteins by mass spectrometry. In addition to previously known interactors, such as the ubiquitin E3-ligase
HRD1, the authors report new elements of the dislocation machinery in mammalian cells. Among these are the E2 ubiquitin-
conjugating enzymeUBC6e, the ancient ubiquitous protein 1 (AUP1), and theUBX domain containing protein 8 (UBXD8). They
also provide evidence from the overexpression of wild-type and dominant-negative constructs that each of these proteins is
critical to glycoprotein dislocation. Hence, this work, which more fully characterizes the elements of the mammalian disloca-
tionmachinery, is a starting point for determining how the activities of these ER-membrane-bound proteins are coordinated in
the removal of misfolded glycoproteins.
B. Mueller et al. (2008). Proc. Natl. Acad. Sci. U.S.A. 105, 12325–12330.
HSF1 Provides Protection from PrP
Protein misfolding is a common feature of many forms of neurodegeneration. In
a mousemodel of prion disease, Steele et al. (2008) now show that the transcriptional
regulator heat shock factor 1 (HSF1) extends life span, and does so without affecting
the age of symptom onset. The authors examined the survival of wild-type and HSF1
knockout mice after inoculation with murine-adapted scrapie prions. Scrapie leads to
neurodegeneration in sheep and goats and is closely related to bovine spongiform
encephalopathy (‘‘mad cow disease’’). The authors observe that the time to the onset
of symptoms,both histological andbehavioral, is similar betweenwild-typeandHSF1-
deficientmice (4.5monthsafter inoculationwith theprion).Yet, theprogressionof the
disease is markedly accelerated in HSF1-deficient mice. Given that HSF1 triggers the
expression of heat shock proteins, which assist in protein folding, the authors exam-
ined whether loss of HSF1 altered the accumulation of prion protein (PrP) aggregates.
However, the accumulation of PrP aggregates, as measured by proteinase K diges-
tion, appeared to be similar between wild-type and HSF1-deficient mice. Although
HSF1 does not appear to alter the accumulation of PrP aggregates, future work may
show whether it alleviates a more generalized form of protein-folding stress brought
on by PrP toxicity. Despite uncertainty as to the mechanism of protection, these find-
ings suggest that enhancing the activity of HSF1 might be beneficial in some disease
contexts and that a therapeutic strategy targeting HSF1would not necessarily require intervention at a presymptomatic stage.
A. D. Steele et al. (2008). Proc. Natl. Acad. Sci. U.S.A. 105, 13626–13631.
Aggregates Set Off Factor XII
ActivationofFactorXII, a serineprotease inbloodplasma,mediatesmultipleprocesses,
including vasodilation, pain, and inflammation. Although Factor XII can be activated in
experimental settings by surface materials with a negative charge, such as glass, the
physiological regulators of Factor XII remain undiscovered. A new report by Maas
et al. (2008) suggests that in vivo, Factor XII is poised to detect the presence of aggre-
gates of misfolded proteins in the blood. Previous work has found that the activity of
Factor XII is elevated in the cerebral spinal fluid of patients with Alzheimer’s disease.
In the newworkbyMaaset al., the authors provide evidence that the response of Factor
XII to misfolded protein may be a general phenomenon. They report that Factor XII ac-
tivation iselevated inpatientswithsystemicamyloidosisanddiscover that it ismisfolded
aggregates and not amyloid fibrils that are key to activating Factor XII. Factor XII then
activate kallikreins,which are serineproteases that cleaveprecursor proteins to liberate
inflammatory mediators, such as bradykinin. Interestingly, contact with surfaces also
initiates coagulation of blood, but Maas et al. show that the activation of Factor XII in
response to misfolded proteins leads only to kallikrein activation, and does not initiate
coagulation, suggesting thatactivationofkallikrein-kininsystemcanoccur independent
of the coagulation cascade. Future work may explore the molecular mechanisms by
which Factor XII detects and becomes activated by aggregates of misfolded protein.
C. Maas et al. (2008). J. Clin. Invest. 118, 3208–3218.
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